phenoxybenzamine has been researched along with Experimental Hepatoma in 2 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackerman, NB | 2 |
| Makohon, S | 1 |
| Jacobs, R | 1 |
| Bloom, ND | 1 |
| Poon, TT | 1 |
2 other studies available for phenoxybenzamine and Experimental Hepatoma
| Article | Year |
|---|---|
The blood supply of experimental liver metastases. VII. Further studies on increased tumor vascularity caused by epinephrine.
Topics: Animals; Carcinoma 256, Walker; Epinephrine; Liver Neoplasms; Liver Neoplasms, Experimental; Microci | 1984 |
Increased capillary flow in intrahepatic tumors due to alpha-adrenergic effects of catecholamines.
Topics: Animals; Carcinoma 256, Walker; Epinephrine; Female; Isoproterenol; Liver Circulation; Liver Neoplas | 1988 |